Healthcare-Associated Infections in Ukraine and the Activity of 4-Thiazolidinone Derivatives Against Related Pathogens

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2024

Conditions
Nosocomial Infection
Interventions
DIAGNOSTIC_TEST

Microbiological Diagnostic Testing

"This study involves microbiological diagnostic testing of clinical samples collected from ICU patients diagnosed with healthcare-associated infections (HAIs). The intervention includes:~Sample Collection: Blood, urine, sputum, bronchoalveolar lavage, wound swabs, and oropharyngeal/nasopharyngeal swabs.~Pathogen Identification: Using biochemical tests, MALDI-TOF mass spectrometry, and 16S rRNA sequencing to identify bacterial and fungal pathogens.~Antimicrobial Susceptibility Testing: Determining the resistance profiles of the identified pathogens to various antimicrobial agents.~Evaluation of New Compounds: Testing the antimicrobial efficacy of new 4-thiazolidinone derivatives against isolated pathogens.~This comprehensive approach aims to enhance the understanding of pathogen distribution and resistance patterns in HAIs."

Trial Locations (1)

79010

Danylo Halytsky Lviv National Medical University, Lviv

All Listed Sponsors
lead

Danylo Halytsky Lviv National Medical University

OTHER

NCT06508398 - Healthcare-Associated Infections in Ukraine and the Activity of 4-Thiazolidinone Derivatives Against Related Pathogens | Biotech Hunter | Biotech Hunter